- Report
- January 2023
- 120 Pages
Global
From €4465EUR$4,500USD£3,705GBP
- Report
- May 2023
- 140 Pages
Global
From €5953EUR$5,999USD£4,939GBP
- Report
- May 2023
- 140 Pages
Global
From €5953EUR$5,999USD£4,939GBP
- Report
- August 2023
- 85 Pages
Global
From €3500EUR$3,778USD£3,006GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$3,778USD£3,006GBP
- Report
- July 2022
- 288 Pages
Global
From €3543EUR$3,570USD£2,939GBP
- Book
- January 2022
- 400 Pages
The Viral Inactivation market is a subset of the biotechnology industry that focuses on the development of technologies and processes to inactivate viruses. This is done through a variety of methods, such as chemical treatments, physical treatments, and irradiation. These treatments are used to reduce the risk of contamination and to ensure the safety of products, such as pharmaceuticals, biologics, and medical devices. Viral inactivation is also used in the production of vaccines and other biologics.
Viral inactivation is an important part of the biotechnology industry, as it helps to ensure the safety of products and reduce the risk of contamination. It is also used to improve the efficacy of products, such as vaccines.
Some companies in the Viral Inactivation market include Merck, Sartorius, Lonza, and Thermo Fisher Scientific. Show Less Read more